Cargando…

Effect of Extracellular Signal-Regulated Protein Kinase 5 Inhibition in Clear Cell Renal Cell Carcinoma

(1) Background: Extracellular signal-regulating kinase 5 (ERK5) has been implicated in many cellular functions, including survival, proliferation, and vascularization. Our objectives were to examine the expression and effect of ERK5 in clear cell renal cell carcinoma (ccRCC). (2) Methods: The expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanno, Hidenori, Naito, Sei, Obara, Yutaro, Ito, Hiromi, Ichiyanagi, Osamu, Narisawa, Takafumi, Kato, Tomoyuki, Nagaoka, Akira, Tsuchiya, Norihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369143/ https://www.ncbi.nlm.nih.gov/pubmed/35955582 http://dx.doi.org/10.3390/ijms23158448

Ejemplares similares

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma
por: Narisawa, Takafumi, et al.
Publicado: (2023)

Expression of Extracellular Signal-regulated Kinase 5 and Ankyrin Repeat Domain 1 in Composite Pheochromocytoma and Ganglioneuroblastoma Detected Incidentally in the Adult Adrenal Gland
por: Suenaga, Shinta, et al.
Publicado: (2016)

Impact of eIF4E phosphorylation at Ser209 via MNK2a on tumour recurrence after curative surgery in localized clear cell renal cell carcinoma
por: Ichiyanagi, Osamu, et al.
Publicado: (2019)

GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition
por: Ito, Hiromi, et al.
Publicado: (2016)

Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Kurota, Yuta, et al.
Publicado: (2023)

Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma
por: Sabrina, Saima, et al.
Publicado: (2023)

A GRIA2 and PAX8-positive renal solitary fibrous tumor with NAB2-STAT6 gene fusion
por: Ichiyanagi, Osamu, et al.
Publicado: (2015)

Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinoma
por: Naito, Sei, et al.
Publicado: (2019)

Effect of third- and fourth-line systemic therapies for metastatic renal cell carcinoma
por: Naito, Sei, et al.
Publicado: (2019)

Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients
por: Takai, Satoshi, et al.
Publicado: (2022)

Primary mesenchymal chondrosarcoma of the kidney without HEY1-NCOA2 and IRF2BP2-CDX1 fusion: A case report and review
por: Yamagishi, Atsushi, et al.
Publicado: (2020)

Clinical relevance of seasonal changes in the prevalence of ureterolithiasis in the diagnosis of renal colic
por: Fukuhara, Hiroki, et al.
Publicado: (2016)

Living kidney transplantation without perioperative anticoagulation therapy for a patient with heparin‐induced thrombocytopenia
por: Nishida, Hayato, et al.
Publicado: (2020)

Body composition changes following chemotherapy for testicular germ cell tumor: obesity is the long-term problem
por: Takai, Yuki, et al.
Publicado: (2021)

Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette–Guérin
por: Takeda, Yuji, et al.
Publicado: (2023)

Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma
por: Kurokawa, Masayuki, et al.
Publicado: (2023)

A durable complete response resulting from treatment with nivolumab plus ipilimumab for metastatic collecting duct carcinoma of the kidney
por: Funajima, Keisuke, et al.
Publicado: (2023)

Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
por: Kato, Renpei, et al.
Publicado: (2022)

Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study
por: Kato, Renpei, et al.
Publicado: (2023)

Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
por: Numakura, Kazuyuki, et al.
Publicado: (2021)

Clinical impact of early response to first‐line VEGFR‐TKI in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study
por: Sobu, Ryuta, et al.
Publicado: (2022)

GPI-80 Augments NF-κB Activation in Tumor Cells
por: Takeda, Yuji, et al.
Publicado: (2021)

Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus
por: Kurokawa, Masayuki, et al.
Publicado: (2020)

Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor
por: Segawa, Keiko, et al.
Publicado: (2018)

Comprehensive analysis of somatic copy number alterations in clear cell renal cell carcinoma
por: Tsuyukubo, Takashi, et al.
Publicado: (2020)

Effects of salivary protein flow and indigenous microorganisms on initial colonization of Candida albicans in an in vivo model
por: Kanaguchi, Norihiko, et al.
Publicado: (2012)

Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma
por: Tsuchiya, Norihiko, et al.
Publicado: (2014)

Reply to: MIDN locus structural variants and Parkinson’s disease risk
por: Obara, Yutaro, et al.
Publicado: (2020)

Midnolin is a confirmed genetic risk factor for Parkinson’s disease
por: Obara, Yutaro, et al.
Publicado: (2019)

The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma
por: Oxburgh, Leif
Publicado: (2022)

Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma
por: Fujii, Nakanori, et al.
Publicado: (2017)

Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
por: Ota, Yukihide, et al.
Publicado: (2021)

Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma
por: Sato, Kazunari, et al.
Publicado: (1999)

Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease
por: Obara, Yutaro, et al.
Publicado: (2017)

Relationship between miR‐155 expression and clear cell papillary renal cell carcinoma in the dialyzed kidney
por: Shiomi, Ei, et al.
Publicado: (2021)

Clear cell sarcoma of the kidney distinguished from synovial sarcoma using genetic analysis: a case report
por: Hirose, Masahito, et al.
Publicado: (2015)

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab
por: Takahashi, Shuhei, et al.
Publicado: (2022)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
por: Shibasaki, Noboru, et al.
Publicado: (2015)

Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma
por: Yamazaki, Hiroyuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1vbe7jghektodi0aj7b8pbrccm